hero section gradient
10 handpicked stocks

Gold & Silver

Will investing in these metal mining stocks make your portfolio sparkle? These carefully selected precious metal companies were chosen by our professional analysts for their potential to serve as a hedge against economic uncertainty. Discover how gold and silver miners could add stability and growth to your investments.

Author avatar

Han Tan | Market Analyst

Published on May 4

Your Basket's Financial Footprint

Summary of total market capitalisation and breakdown for the Gold & Silver basket.

Key Takeaways for Investors:
  • Large-cap dominance tends to lower volatility, offering more stability and closer tracking of broader market moves.
  • Appropriate as a core holding for diversified portfolios, not primarily for speculative short-term bets.
  • Likely to deliver steady, long-term value rather than rapid, explosive short-term gains.
Total Market Cap
  • NEM: $94.82B

  • RGLD: $15.59B

  • KGC: $29.62B

  • Other

About This Group of Stocks

1

Our Expert Thinking

Gold and silver mining stocks offer a potential hedge against inflation and economic volatility. These metals have historically preserved value during uncertain times, while also playing crucial roles in technology and industry, creating dual sources of demand and opportunity.

2

What You Need to Know

The global gold market is valued at approximately $200 billion and growing, while the silver market is projected to reach $20 billion by 2027. These mining companies provide exposure to precious metals without having to own physical gold or silver.

3

Why These Stocks

We've selected industry leaders like Barrick Gold, Newmont, and Franco-Nevada based on their market position, growth potential, and ability to capitalize on increasing demand for precious metals in both investment and industrial applications.

Why You'll Want to Watch These Stocks

🛡️

Inflation Protection

Gold and silver have historically acted as hedges against inflation and currency devaluation. As economic uncertainty increases, these mining stocks could become even more valuable to your portfolio.

📱

Tech-Driven Demand

Silver's growing use in electronics, solar panels, and other technologies is creating fresh demand beyond traditional investment. The industrial applications for these metals continue to expand, potentially driving future growth.

💎

Portfolio Diversification

Adding precious metal miners to your investments can help reduce overall portfolio risk. When other sectors struggle during market volatility, gold and silver stocks often provide a counterbalance.

Get the full story on this Basket. Read our detailed article on its risks and potential.

Read Full Insight

Why Invest with Nemo Money?

Nemo Logo Fade
🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

🚀

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Discover More Opportunities

Tech Stocks (AI Valuation Reset) Present Potential Entry

Tech Stocks (AI Valuation Reset) Present Potential Entry

Recent market turmoil, driven by concerns over AI stock valuations, has led to a significant drop in global markets. This correction creates a potential opportunity to invest in fundamentally sound technology companies at more attractive prices.

Walmart Succession Plan Explained | Market Effects

Walmart Succession Plan Explained | Market Effects

Walmart announced a CEO transition, with veteran John Furner taking the helm, which could create opportunities for competitors. This leadership change at a retail giant may cause short-term uncertainty, potentially benefiting other major players in the retail space.

Biotech Buyout Candidates (Post-Merck Acquisition)

Biotech Buyout Candidates (Post-Merck Acquisition)

Merck's $9.2 billion acquisition of Cidara Therapeutics for its antiviral drug pipeline signals a broader industry trend. This creates an investment opportunity in other biotech companies with promising late-stage drugs that could become the next acquisition targets for pharmaceutical giants.

Frequently Asked Questions